Related Experiment Video
Updated: Sep 25, 2026

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
SCRIB inhibits PP1 phosphatase activity without blocking or structurally altering its active site
Siba Alharbi1, Amit Kumawat2, Brandon Huntington1
1KAUST Center of Excellence for Smart Health, Biomedical Sciences Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Kingdom of Saudi Arabia.
Abstract:
Protein phosphorylation is a fundamental mechanism regulating cellular function, governed by the opposing actions of kinases and phosphatases. The substrate specificity and catalytic activity of protein phosphatase 1 (PP1), a major serine/threonine phosphatase, results from its interactions with more than 200 regulatory proteins. However, the mechanisms employed remain largely unknown. Here, we present the 3.5 Å cryo-electron microscopy structure of the complex between PP1 and the tumor suppressor and negative ERK-signaling regulator scribble homologue (SCRIB), revealing an unprecedented inhibitory mechanism. SCRIB engages PP1 via a multipronged interface composed of its leucine-rich repeat (LRR) domain, its first PDZ domain, and its flanking regions, where the 705KGVSF sequence acts as a non-canonical PP1-binding RVxF motif. Enzymatic kinetics demonstrate that SCRIB potently dampens catalytic turnover (kcat) while preserving PP1 in a fully ion-loaded, "active-like" state. Structural, computational, and evolutionary analyses suggest that SCRIB achieves this inhibition by allosterically modulating the electrostatic landscape and rigidifying the dynamic properties of the PP1 core. These findings identify SCRIB as the first known PP1 regulator that suppresses catalytic activity by conformationally locking an active-like state, rather than by disrupting the active site or occluding substrate-binding grooves. By sequestering PP1 in a primed yet silenced state, SCRIB establishes a latent cortical pool that provides a molecular mechanism for rapid, localized phosphatase activation following upstream stimuli.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Feedback Inhibition
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Enzyme Inhibition
The JAK-STAT Signaling Pathway
